Annual report pursuant to Section 13 and 15(d)

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration (Details)

v3.22.4
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Concentration (Details) - Supplier Concentration Risk
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Research and development expenditures | Vendor One    
Concentration    
Concentration Risk (as a percent) 55.00% 42.00%
Research and development expenditures | Vendor Two    
Concentration    
Concentration Risk (as a percent) 4.00% 15.00%
Accounts payable and accrued expense | Vendor One    
Concentration    
Concentration Risk (as a percent) 56.00% 5.00%